Prophase Labs Stock Market Value
| PRPH Stock | USD 0.47 0.05 11.90% |
| Symbol | ProPhase |
ProPhase Labs Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ProPhase Labs. If investors know ProPhase will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ProPhase Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.95) | Earnings Share (2.23) | Revenue Per Share | Quarterly Revenue Growth (0.39) | Return On Assets |
The market value of ProPhase Labs is measured differently than its book value, which is the value of ProPhase that is recorded on the company's balance sheet. Investors also form their own opinion of ProPhase Labs' value that differs from its market value or its book value, called intrinsic value, which is ProPhase Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProPhase Labs' market value can be influenced by many factors that don't directly affect ProPhase Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ProPhase Labs' value and its price as these two are different measures arrived at by different means. Investors typically determine if ProPhase Labs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProPhase Labs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
ProPhase Labs 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to ProPhase Labs' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of ProPhase Labs.
| 04/28/2025 |
| 07/27/2025 |
If you would invest 0.00 in ProPhase Labs on April 28, 2025 and sell it all today you would earn a total of 0.00 from holding ProPhase Labs or generate 0.0% return on investment in ProPhase Labs over 90 days. ProPhase Labs is related to or competes with Agilent Technologies, Equillium, KING PHARMACEUTICALS, DiaMedica Therapeutics, Valneva SE, Vivani Medical, and Denali Therapeutics. ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the cou... More
ProPhase Labs Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure ProPhase Labs' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess ProPhase Labs upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 7.18 | |||
| Information Ratio | 0.0696 | |||
| Maximum Drawdown | 27.95 | |||
| Value At Risk | (11.90) | |||
| Potential Upside | 10.0 |
ProPhase Labs Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for ProPhase Labs' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as ProPhase Labs' standard deviation. In reality, there are many statistical measures that can use ProPhase Labs historical prices to predict the future ProPhase Labs' volatility.| Risk Adjusted Performance | 0.0894 | |||
| Jensen Alpha | 0.0939 | |||
| Total Risk Alpha | (0.94) | |||
| Sortino Ratio | 0.0589 | |||
| Treynor Ratio | 0.2348 |
ProPhase Labs Backtested Returns
ProPhase Labs appears to be risky, given 3 months investment horizon. ProPhase Labs maintains Sharpe Ratio (i.e., Efficiency) of 0.11, which implies the firm had a 0.11 % return per unit of risk over the last 3 months. By analyzing ProPhase Labs' technical indicators, you can evaluate if the expected return of 0.65% is justified by implied risk. Please evaluate ProPhase Labs' Semi Deviation of 5.56, risk adjusted performance of 0.0894, and Coefficient Of Variation of 961.04 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, ProPhase Labs holds a performance score of 8. The company holds a Beta of 2.65, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, ProPhase Labs will likely underperform. Please check ProPhase Labs' value at risk, as well as the relationship between the skewness and day median price , to make a quick decision on whether ProPhase Labs' historical price patterns will revert.
Auto-correlation | 0.31 |
Below average predictability
ProPhase Labs has below average predictability. Overlapping area represents the amount of predictability between ProPhase Labs time series from 28th of April 2025 to 12th of June 2025 and 12th of June 2025 to 27th of July 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of ProPhase Labs price movement. The serial correlation of 0.31 indicates that nearly 31.0% of current ProPhase Labs price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.31 | |
| Spearman Rank Test | 0.29 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
ProPhase Labs lagged returns against current returns
Autocorrelation, which is ProPhase Labs stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting ProPhase Labs' stock expected returns. We can calculate the autocorrelation of ProPhase Labs returns to help us make a trade decision. For example, suppose you find that ProPhase Labs has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
ProPhase Labs regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If ProPhase Labs stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if ProPhase Labs stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in ProPhase Labs stock over time.
Current vs Lagged Prices |
| Timeline |
ProPhase Labs Lagged Returns
When evaluating ProPhase Labs' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of ProPhase Labs stock have on its future price. ProPhase Labs autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, ProPhase Labs autocorrelation shows the relationship between ProPhase Labs stock current value and its past values and can show if there is a momentum factor associated with investing in ProPhase Labs.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
| USOI | Credit Suisse X Links | |
| ULTY | Tidal Trust II | |
| CONY | YieldMax N Option | |
| BCAT | BlackRock Capital Allocation | |
| PDI | Pimco Dynamic Income |
Check out ProPhase Labs Correlation, ProPhase Labs Volatility and ProPhase Labs Alpha and Beta module to complement your research on ProPhase Labs. For more detail on how to invest in ProPhase Stock please use our How to Invest in ProPhase Labs guide.You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
ProPhase Labs technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.